The Philippines' Food and Drug Administration on Tuesday said it had cleared the COVID-19 vaccine manufactured by China's Sinovac for emergency use on minors as young as six years old as the government expands inoculation to more populations.
CoronaVac is the third COVID-19 vaccine authorized by the FDA to be used for the pediatric age group after Pfizer and Moderna. It was recommended to be administered in two doses four weeks apart.
"Based on the evidence submitted which includes clinical trials and real-world effectiveness data, CoronaVac was found to have acceptable immunogenicity and safety profile in pediatric groups," the FDA said in a statement.
"The assessment done ensured that the benefits outweigh the known and potential risks of the product based on the totality of evidence presented and available data," it added.
With COVID-19 vaccines now available for young children, the FDA reminded parents and guardians to have their kids vaccinated by healthcare providers who are trained to recognize and manage adverse reactions.
As of March 13, over 64 million Filipinos have been fully vaccinated against COVID-19, of which more than 11 million have received their booster shots, the Department of Health said.